WHO ICTRP trial

A clinical trial about Comparing effectiveness and side effects of…

CTRI/2024/03/064148 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/03/064148
Public title A clinical trial about Comparing effectiveness and side effects of Amoxicillin-clavulanic acid versus ciprofloxacin in patient of chronic suppurative otitis media in a hospital
Scientific title Comparison of efficacy and safety of Amoxicillin-clavulanic acid versus ciprofloxacin in patient of active stage of tubotympanic type of chronic suppurative otitis media in a tertiary care hospital - a prospective, randomized, Open-label study - nil
Primary sponsor Indira Gandhi Government medical college and Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: H661- Chronic tubotympanic suppurative otitis media
Interventions Intervention1: Amoxicillin- clavulanic acid: a single 625 mg tablet given orally twice a day for 7 days Control Intervention1: Ciprofloxacin: 500mg tablet given orally twice a day for 7 days
Registration date Mar 14, 2024
Target size 74
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations